Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GOP Action To Push Through ACA-Replace Bill Threatens Device Tax Repeal

Executive Summary

Republican action to ram an Affordable Care Act replacement bill through two House committees overnight, without a Congressional Budget Office score and over the objections of powerful health-care interests, appears to be undermining support for the American Health Care Act, threatening ultimate congressional passage of the bill and its device-tax repeal provision.

You may also be interested in...



User Fee Bill Could Become Ensnared In US Abortion Politics

Amendment defunding Planned Parenthood is one ACA repeal refugee that could hitch a ride with user fee bill, which would be 'problematic,' to say the least, for Democrats.

Device-Tax Repeal In Doubt As House Postpones Health Bill Vote

US House Republicans canceled a planned vote on the "repeal and replace" American Health Care Act March 23 after failing to secure enough support to ensure passage of the measure. Republicans are still trying salvage a compromise, but the developments threaten industry's goal of achieving a permanent repeal of the medical device tax in the near term.

Trump's Sights Set On Payers And Pharmas, But Medtechs Must Not Be Complacent

It's been a big month for plans intended to shape the future of health care in the US, with the Trump Administration showcasing its ACA replacement bill and issuing budget proposals. At this stage, it's hard to peg winners and losers and although the focus is squarely on insurance, the medtech sector should guard against complacency, says ZS Associates' Brian Chapman.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT104559

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel